New Delhi [India], August 20 (ANI): Zydus Cadila's wait for a regulatory nod for its ZyCoV-D plasmid DNA vaccine against Covid is over. The Ahmedabad-based pharma company has received approval from the Drugs Controller General of India (DCGI).
New Delhi [India], August 10 (ANI): The Delhi High Court on Tuesday allowed the petitioner to withdraw his Public Interest Litigation (PIL) seeking the sale of Remdesivir, used in COVID-19 treatment, in the domestic market.
Hyderabad (Telangana) [India], June 28 (ANI): Dr. Reddy's Laboratories Limited on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG), an anti-COVID-19 drug.
New Delhi [India], June 22 (ANI): The National Human Rights Commission (NHRC) chairman Justice (Retired) Arun Mishra on Tuesday said the right to life should prevail over the rights of patent holders to ensure that the scarcity of life-saving drugs, medicines and vaccines relating to COVID-1
New Delhi [India], June 22 (ANI): US pharmaceutical giant Pfizer on Tuesday said it is in the "final stages" of getting approval for its COVID-19 vaccine in India.
New Delhi [India], June 9 (ANI): The Defence Research and Development Organisation (DRDO), which developed 2 -Deoxy-D-Glucose (2-DG), a drug used for the treatment of COVID-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industr
New Delhi [India], June 3 (ANI): The Drug Controller of Delhi on Thursday informed the Delhi High Court that Gautam Gambhir Foundation has committed an offence under the Drugs and Cosmetics Act for hoarding unauthorised stock of COVID-19 drugs.
New Delhi [India], June 1 (ANI): The Defence Research and Development Organisation's (DRDO) on Tuesday said that the anti-COVID drug 2DG is approved for emergency use as an adjunct therapy to the standard of care in the treatment of coronavirus patients in hospital settings.
New Delhi [India], May 28 (ANI): Defence Research and Development Organisation's (DRDO) anti-Covid-19 drug will be sold at Rs 990 per sachet by Dr Reddy's Laboratories (DRL), officials said on Friday. The Hyderabad-based pharma company, however, will provide the medicine to Centre and state
New Delhi [India], May 26 (ANI): Fortis Escorts Heart Institute in Delhi is to administer dose of COVID-19 drug cocktail with fast-acting antibodies - Casirivimab and Imdevimab - from tomorrow.
New Delhi [India], May 21 (ANI): Amid the ongoing pandemic, the government is considering the involvement of three or four more firms to ramp up the production of the drug 2DG, developed by the DRDO for the treatment of COVID-19 patients and do away with its scarcity.